Healthcare Realty Trust Incorporated HR
Healthcare Realty Trust operates as a Real Estate Investment Trust (REIT), specializing in the acquisition, development, financing, and active management of income-generating real estate assets, predominantly serving outpatient healthcare providers throughout the United States. By September 30, 2020, its extensive portfolio comprised 211 properties located across 24 states, collectively spanning 15.5 million square feet and valued at approximately $5.5 billion. The company further provided comprehensive leasing and property management solutions for 11.9 million square feet nationwide.
Business overview written from the company's own Form 10-K (Item 1), filed 2026-02-13 — refreshed whenever it files a new one. The figures above are current; see its SEC filings. ✓ From the 10-K
Plain-English: the Snapshot is the quick read — what it pays you (yield, dividend), how its cash flow looks (FFO/AFFO, Price/OCF) and how much debt it carries. Switch to Expert in the header to hide these explanations.
Snapshot
Reported FFO / AFFO / leverage are from the Q1 2026 earnings release (filed 2026-04-30) — 8-K, EX-99.1 ✓ Verified to filing.
Yield uses the latest declared dividend, annualized (latest regular payout × frequency; special/liquidating distributions excluded) — an announced-but-not-yet-declared change isn't reflected until it has an ex-date. FFO, AFFO and Net debt / Adj. EBITDA are the company's reported figures from its latest earnings 8-K. Price/OCF and payout use GAAP operating cash flow. NAV premium and credit ratings have no free source yet. See Methodology.
$10,000 invested
Illustrative income only, at today's price and latest declared dividend — it excludes price changes, dividend cuts and taxes. Not a forecast.
Model HR yourself — any amount, shares, per-payment & a multi-year DRIP projection →
Balance sheet (latest FY: 2025)
Debt-maturity ladder, fixed/floating split, secured/unsecured and coverage ratios come from the supplemental — not yet ingested.
Financial history
| FY | Revenue | Net income | D&A | EBITDA | Op. cash flow |
|---|---|---|---|---|---|
| 2025 | $1.18B | $-246.07M | $563.97M | $519.96M | $457.10M |
| 2024 | $1.27B | $-654.49M | $722.32M | $313.79M | $501.62M |
| 2023 | $1.34B | $-278.26M | $775.89M | $762.47M | $499.82M |
| 2022 | $932.64M | $40.90M | $477.78M | $660.40M | $272.75M |
| 2021 | $534.82M | $66.66M | $206.51M | $325.69M | $232.63M |
| 2020 | $735.07M | $52.62M | $194.82M | $248.32M | $470.09M |
Dividends
Recent regular dividends per share (special distributions excluded), oldest → newest.
| Ex-date | Record | Payment | Declared | Amount | Freq. |
|---|---|---|---|---|---|
| 2026-08-11 | 2026-08-11 | 2026-08-26 | 2026-07-30 | $0.24 | Quarterly |
| 2026-05-11 | 2026-05-11 | 2026-05-22 | 2026-04-30 | $0.24 | Quarterly |
| 2026-02-24 | 2026-02-24 | 2026-03-11 | 2026-02-12 | $0.24 | Quarterly |
| 2025-11-10 | 2025-11-11 | 2025-11-21 | 2025-10-30 | $0.24 | Quarterly |
| 2025-08-14 | 2025-08-14 | 2025-08-28 | 2025-07-31 | $0.24 | Quarterly |
| 2025-05-12 | 2025-05-12 | 2025-05-23 | 2025-05-01 | $0.31 | Quarterly |
| 2025-03-03 | 2025-03-03 | 2025-03-19 | 2025-02-19 | $0.31 | Quarterly |
| 2024-11-12 | 2024-11-12 | 2024-11-27 | 2024-10-29 | $0.31 | Quarterly |
| 2024-08-12 | 2024-08-12 | 2024-08-28 | 2024-07-30 | $0.31 | Quarterly |
| 2024-05-10 | 2024-05-13 | 2024-05-23 | 2024-04-30 | $0.31 | Quarterly |
| 2024-02-23 | 2024-02-26 | 2024-03-14 | 2024-02-13 | $0.31 | Quarterly |
| 2023-11-13 | 2023-11-14 | 2023-11-30 | 2023-10-30 | $0.31 | Quarterly |
| 2023-08-14 | 2023-08-15 | 2023-08-30 | 2023-08-01 | $0.31 | Quarterly |
| 2023-05-15 | 2023-05-16 | 2023-06-02 | 2023-05-02 | $0.31 | Quarterly |
| 2023-03-06 | 2023-03-07 | 2023-03-21 | 2023-02-24 | $0.31 | Quarterly |
| 2022-11-14 | 2022-11-15 | 2022-11-30 | 2022-11-02 | $0.31 | Quarterly |
| 2022-08-12 | 2022-08-15 | 2022-08-30 | 2022-08-03 | $0.11 | Monthly |
| 2022-07-21 | 2022-07-19 | 2022-07-27 | 2022-07-06 | $4.82 | Special |
| 2022-07-13 | 2022-07-14 | 2022-07-19 | 2022-07-01 | $0.03 | Irregular |
| 2022-07-05 | 2022-07-06 | 2022-07-15 | 2022-05-05 | $0.33 | Irregular |
| 2022-05-13 | 2022-05-03 | 2022-05-27 | 2022-05-03 | $0.31 | Irregular |
| 2022-04-01 | 2022-04-04 | 2022-04-11 | 2022-02-28 | $0.33 | Monthly |
| 2022-02-25 | 2022-02-22 | 2022-03-15 | 2022-02-22 | $0.31 | Irregular |
| 2022-01-03 | 2022-01-04 | 2022-01-11 | 2021-11-04 | $0.33 | Irregular |
Coverage (payout of operating cash flow): 73.47%. Tax-character split (ordinary / 199A / capital gain / return of capital) — not disclosed (requires the annual allocation release).
Recent news — HR
Lilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) Congress
Healthcare Realty Trust Releases Eighth Corporate Responsibility Report
Healthcare Realty Trust Announces Third Quarter Earnings Release Date and Conference Call
Pensionfund PDN Acquires 59,719 Shares of Healthcare Realty Trust Incorporated $HR
Corient Private Wealth LP Purchases 30,584 Shares of Healthcare Realty Trust Incorporated $HR
State Street Corp Reduces Stock Position in Healthcare Realty Trust Incorporated $HR
Down 5.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Healthcare Realty Trust (HR)
PureTech Announces Successful End-of-Phase 1 Meeting with U.S. Food and Drug Administration (FDA) and Receipt of Fast Track Designation for LYT-200 in Relapsed/Refractory (R/R) High-Risk Myelodysplast
Headlines via Financial Modeling Prep; links open the original publisher in a new tab. Not an endorsement or investment advice.
Other Health Care REITs
Same-store NOI, occupancy, leasing/WALT, top tenants, external-manager fees, development pipeline and (for non-traded vehicles) share-class fees, redemption/gating and NAV methodology are planned modules sourced from supplementals and prospectuses.